Growth factors can activate ATF2 via a two‐step mechanism: phosphorylation of Thr71 through the Ras–MEK–ERK pathway and of Thr69 through RalGDS–Src–p38
Open Access
- 15 July 2002
- journal article
- research article
- Published by Springer Nature in The EMBO Journal
- Vol. 21 (14) , 3782-3793
Abstract
Transcription factor ATF2 regulates gene expression in response to environmental changes. Upon exposure to cellular stresses, the mitogen‐activated proteinkinase (MAPK) cascades including SAPK/JNK and p38 can enhance ATF2's transactivating function through phosphorylation of Thr69 and Thr71. How ever, the mechanism of ATF2 activation by growth factors that are poor activators of JNK and p38 is still elusive. Here, we show that in fibroblasts, insulin, epidermal growth factor (EGF) and serum activate ATF2 via a so far unknown two‐step mechanism involving two distinct Ras effector pathways: the Raf–MEK–ERK pathway induces phosphorylation of ATF2 Thr71, whereas subsequent ATF2 Thr69 phosphorylation requires the Ral–RalGDS–Src–p38 pathway. Cooperation between ERK and p38 was found to be essential for ATF2 activation by these mitogens; the activity of p38 and JNK/SAPK in growth factor‐stimulated fibroblasts is insufficient to phosphorylate ATF2 Thr71 or Thr69 + 71 significantly by themselves, while ERK cannot dual phosphorylate ATF2 Thr69 + 71 efficiently. These results reveal a so far unknown mechanism by which distinct MAPK pathways and Ras effector pathways cooperate to activate a transcription factor.Keywords
This publication has 64 references indexed in Scilit:
- AP-1 in cell proliferation and survivalOncogene, 2001
- The small-GTPase RalA activates transcription of the urokinase plasminogen activator receptor (uPAR) gene via an AP1-dependent mechanismOncogene, 2001
- The Kinetic Mechanism of the Dual Phosphorylation of the ATF2 Transcription Factor by p38 Mitogen-activated Protein (MAP) Kinase αJournal of Biological Chemistry, 2001
- ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylationNature, 2000
- The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1AOncogene, 1999
- Activation of the Rat Cyclin A Promoter by ATF2 and Jun Family Members and Its Suppression by ATF4Experimental Cell Research, 1998
- ATF2 confers radiation resistance to human melanoma cellsOncogene, 1998
- Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosisNature, 1996
- ATF3 GeneJournal of Biological Chemistry, 1996
- A c-jun dominant negative mutant protects sympathetic neurons against programmed cell deathNeuron, 1995